Nissay Asset Management Corp Japan ADV increased its holdings in shares of Cigna Corp (NYSE:CI) by 61.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 50,508 shares of the health services provider’s stock after acquiring an additional 19,194 shares during the quarter. Nissay Asset Management Corp Japan ADV’s holdings in Cigna were worth $9,592,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also bought and sold shares of CI. Calamos Advisors LLC boosted its position in shares of Cigna by 68.6% during the 3rd quarter. Calamos Advisors LLC now owns 38,632 shares of the health services provider’s stock valued at $8,045,000 after purchasing an additional 15,719 shares in the last quarter. Handelsbanken Fonder AB boosted its position in shares of Cigna by 103.8% during the 3rd quarter. Handelsbanken Fonder AB now owns 2,568 shares of the health services provider’s stock valued at $535,000 after purchasing an additional 1,308 shares in the last quarter. Steward Partners Investment Advisory LLC boosted its position in shares of Cigna by 8.7% during the 3rd quarter. Steward Partners Investment Advisory LLC now owns 3,662 shares of the health services provider’s stock valued at $763,000 after purchasing an additional 292 shares in the last quarter. Ingalls & Snyder LLC bought a new stake in shares of Cigna during the 3rd quarter valued at about $203,000. Finally, Calton & Associates Inc. bought a new stake in shares of Cigna during the 3rd quarter valued at about $322,000. Hedge funds and other institutional investors own 93.44% of the company’s stock.
Shares of Cigna stock opened at $191.87 on Friday. The company has a market capitalization of $47.27 billion, a PE ratio of 13.49, a P/E/G ratio of 0.96 and a beta of 0.72. Cigna Corp has a 52 week low of $163.02 and a 52 week high of $226.60. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.42 and a quick ratio of 0.98.
Cigna (NYSE:CI) last issued its quarterly earnings data on Friday, February 1st. The health services provider reported $2.46 EPS for the quarter, missing the consensus estimate of $2.53 by ($0.07). The company had revenue of $13.75 billion during the quarter, compared to analysts’ expectations of $11.38 billion. Cigna had a return on equity of 16.64% and a net margin of 5.42%. The business’s revenue for the quarter was up 29.3% compared to the same quarter last year. During the same period last year, the company earned $1.94 earnings per share. On average, equities research analysts predict that Cigna Corp will post 16.41 earnings per share for the current fiscal year.
A number of research analysts recently weighed in on CI shares. Edward Jones started coverage on Cigna in a research note on Wednesday, January 2nd. They set a “buy” rating on the stock. BMO Capital Markets upped their price target on Cigna from $220.00 to $230.00 and gave the stock a “hold” rating in a research note on Friday, November 2nd. Morgan Stanley started coverage on Cigna in a research note on Thursday, December 13th. They set an “overweight” rating and a $304.00 price target on the stock. Leerink Swann upped their price target on Cigna from $250.00 to $260.00 and gave the stock an “outperform” rating in a research note on Monday, November 19th. Finally, Citigroup upped their price target on Cigna from $243.00 to $249.00 and gave the stock a “buy” rating in a research note on Friday, November 2nd. Five analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $229.09.
In related news, Director John Partridge sold 1,000 shares of the stock in a transaction that occurred on Thursday, February 7th. The stock was sold at an average price of $184.43, for a total transaction of $184,430.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Michael W. Triplett sold 9,148 shares of the stock in a transaction that occurred on Monday, February 11th. The shares were sold at an average price of $181.01, for a total value of $1,655,879.48. The disclosure for this sale can be found here. Insiders have sold 10,349 shares of company stock valued at $1,882,688 over the last ninety days. 1.10% of the stock is currently owned by company insiders.
Cigna Company Profile
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.
Featured Article: Average Daily Trade Volume – What It Means In Stock Trading
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.